Griese M - Search Results

1

Identifying obstacles hindering the conduct of academic-sponsored trials for drug repurposing on rare-diseases: an analysis of six use cases.

Del Álamo M, Bührer C, Fisher D, Griese M, Lingor P, Palladini G, Sireau N, Hivert V, Sangiorgi L, Guillot F, Halftermeyer J, Soucková L, Nosková K, Demlová R. Del Álamo M, et al. Among authors: griese m. Trials. 2022 Sep 15;23(1):783. doi: 10.1186/s13063-022-06713-y. Trials. 2022. PMID: 36109818 Free PMC article.

2

Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial.

Griese M, Köhler M, Witt S, Sebah D, Kappler M, Wetzke M, Schwerk N, Emiralioglu N, Kiper N, Kronfeld K, Ruckes C, Rock H, Anthony G, Seidl E. Griese M, et al. Trials. 2020 Apr 3;21(1):307. doi: 10.1186/s13063-020-4188-4. Trials. 2020. PMID: 32245508 Free PMC article.

3

Hydroxychloroquine in children with interstitial (diffuse parenchymal) lung diseases.

Braun S, Ferner M, Kronfeld K, Griese M. Braun S, et al. Among authors: griese m. Pediatr Pulmonol. 2015 Apr;50(4):410-9. doi: 10.1002/ppul.23133. Epub 2014 Dec 9. Pediatr Pulmonol. 2015. PMID: 25491573 Review.

4

High-Content Screening Identifies Cyclosporin A as a Novel ABCA3-Specific Molecular Corrector.

Forstner M, Lin S, Yang X, Kinting S, Rothenaigner I, Schorpp K, Li Y, Hadian K, Griese M. Forstner M, et al. Among authors: griese m. Am J Respir Cell Mol Biol. 2022 Apr;66(4):382-390. doi: 10.1165/rcmb.2021-0223OC. Am J Respir Cell Mol Biol. 2022. PMID: 34936540

5

Adherence pattern to study drugs in clinical trials by patients with cystic fibrosis.

Pugatsch T, Shoseyov D, Cohen-Cymberknoh M, Hayut B, Armoni S, Griese M, Kerem E. Pugatsch T, et al. Among authors: griese m. Pediatr Pulmonol. 2016 Feb;51(2):143-6. doi: 10.1002/ppul.23344. Epub 2015 Nov 19. Pediatr Pulmonol. 2016. PMID: 26583331

6

Chronic interstitial lung disease in children.

Griese M. Griese M. Eur Respir Rev. 2018 Feb 7;27(147):170100. doi: 10.1183/16000617.0100-2017. Print 2018 Mar 31. Eur Respir Rev. 2018. PMID: 29436403 Free PMC article. Review.

7

Nutritional supplements in cystic fibrosis.

Kappler M, Griese M. Kappler M, et al. Among authors: griese m. BMJ. 2006 Mar 18;332(7542):618-9. doi: 10.1136/bmj.332.7542.618. BMJ. 2006. PMID: 16543303 Free PMC article. No abstract available.

8

Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis.

Latzin P, Fehling M, Bauernfeind A, Reinhardt D, Kappler M, Griese M. Latzin P, et al. Among authors: griese m. J Cyst Fibros. 2008 Mar;7(2):142-6. doi: 10.1016/j.jcf.2007.07.001. Epub 2007 Sep 4. J Cyst Fibros. 2008. PMID: 17766190 Free article. Clinical Trial.

9

Effective improvement of cystic fibrosis care by application of elementary measures: essential lessons not only for developing countries.

Griese M, Kappler M. Griese M, et al. J Pediatr (Rio J). 2008 Sep-Oct;84(5):383-5. doi: 10.2223/JPED.1837. J Pediatr (Rio J). 2008. PMID: 18923794 English, Portuguese. No abstract available.

10

Long-term pulmonary outcome after meconium ileus in cystic fibrosis.

Kappler M, Feilcke M, Schröter C, Kraxner A, Griese M. Kappler M, et al. Among authors: griese m. Pediatr Pulmonol. 2009 Dec;44(12):1201-6. doi: 10.1002/ppul.21119. Pediatr Pulmonol. 2009. PMID: 19911366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

402 results

Search Page